001     136043
005     20250715100517.0
024 7 _ |a 10.1111/j.1468-1331.2010.02985.x
|2 doi
024 7 _ |a pmid:20298421
|2 pmid
024 7 _ |a 1351-5101
|2 ISSN
024 7 _ |a 1468-1331
|2 ISSN
024 7 _ |a 1471-0552
|2 ISSN
024 7 _ |a altmetric:5307761
|2 altmetric
037 _ _ |a DZNE-2020-02365
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Burgunder, J-M
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias.
260 _ _ |a Oxford
|c 2010
|b Blackwell Science78889
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2010-03-09
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2010-05-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1752566682_3117
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a These EFNS guidelines on the molecular diagnosis of channelopathies, including epilepsy and migraine, as well as stroke, and dementia are designed to summarize the possibilities and limitations of molecular genetic techniques and to provide diagnostic criteria for deciding when a molecular diagnostic work-up is indicated.To collect data about planning, conditions, and performance of molecular diagnosis of these disorders, a literature search in various electronic databases was carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed.The best level of evidence for genetic testing recommendation (B) can be found for a small number of syndromes, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, severe myoclonic epilepsy of infancy, familial recurrent hemorrhages, familial Alzheimer's disease, and frontotemporal lobar degeneration. Good practice points can be formulated for a number of other disorders.These guidelines are provisional, and the future availability of molecular genetic epidemiological data about the neurogenetic disorders under discussion in our article will allow improved recommendation with an increased level of evidence.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
542 _ _ |i 2015-09-01
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Channelopathies: diagnosis
|2 MeSH
650 _ 2 |a Channelopathies: epidemiology
|2 MeSH
650 _ 2 |a Channelopathies: genetics
|2 MeSH
650 _ 2 |a Dementia: diagnosis
|2 MeSH
650 _ 2 |a Dementia: epidemiology
|2 MeSH
650 _ 2 |a Dementia: genetics
|2 MeSH
650 _ 2 |a Epilepsy: diagnosis
|2 MeSH
650 _ 2 |a Epilepsy: epidemiology
|2 MeSH
650 _ 2 |a Epilepsy: genetics
|2 MeSH
650 _ 2 |a Europe: epidemiology
|2 MeSH
650 _ 2 |a Evidence-Based Medicine
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Infant, Newborn
|2 MeSH
650 _ 2 |a Migraine Disorders: diagnosis
|2 MeSH
650 _ 2 |a Migraine Disorders: epidemiology
|2 MeSH
650 _ 2 |a Migraine Disorders: genetics
|2 MeSH
650 _ 2 |a Molecular Biology: methods
|2 MeSH
650 _ 2 |a Molecular Biology: standards
|2 MeSH
650 _ 2 |a Molecular Biology: trends
|2 MeSH
650 _ 2 |a Molecular Diagnostic Techniques: methods
|2 MeSH
650 _ 2 |a Molecular Diagnostic Techniques: standards
|2 MeSH
650 _ 2 |a Molecular Diagnostic Techniques: trends
|2 MeSH
650 _ 2 |a Societies, Medical: standards
|2 MeSH
650 _ 2 |a Societies, Medical: trends
|2 MeSH
650 _ 2 |a Stroke: diagnosis
|2 MeSH
650 _ 2 |a Stroke: epidemiology
|2 MeSH
650 _ 2 |a Stroke: genetics
|2 MeSH
700 1 _ |a Finsterer, J.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Szolnoki, Z.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Fontaine, B.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Baets, J.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Van Broeckhoven, C.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Di Donato, S.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a De Jonghe, P.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Lynch, T.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Mariotti, C.
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Schöls, L.
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Spinazzola, A.
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Tabrizi, S. J.
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Tallaksen, C.
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Zeviani, M.
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Harbo, H. F.
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Gasser, T.
|0 P:(DE-2719)2320009
|b 16
|e Last author
700 1 _ |a EFNS
|0 P:(DE-HGF)0
|b 17
773 1 8 |a 10.1111/j.1468-1331.2010.02985.x
|b : Wiley, 2010-03-09
|n 5
|p 641-648
|3 journal-article
|2 Crossref
|t European Journal of Neurology
|v 17
|y 2010
|x 1351-5101
773 _ _ |a 10.1111/j.1468-1331.2010.02985.x
|g Vol. 17, no. 5, p. 641 - 648
|0 PERI:(DE-600)2020241-6
|n 5
|q 17:5<641 - 648
|p 641-648
|t European journal of neurology
|v 17
|y 2010
|x 1351-5101
856 4 _ |u https://pub.dzne.de/record/136043/files/DZNE-2020-02365_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/136043/files/DZNE-2020-02365_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:136043
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)2320009
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Population Studies and Genetics
|x 0
914 1 _ |y 2010
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NEUROL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1046/j.1468-1331.2001.00226.x
|2 Crossref
|o 10.1046/j.1468-1331.2001.00226.x
999 C 5 |9 -- missing cx lookup --
|a 10.1046/j.1468-1331.2001.00228.x
|2 Crossref
|o 10.1046/j.1468-1331.2001.00228.x
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1468-1331.2004.00867.x
|2 Crossref
|o 10.1111/j.1468-1331.2004.00867.x
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.nurt.2007.01.002
|2 Crossref
|o 10.1016/j.nurt.2007.01.002
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/124.6.1091
|2 Crossref
|o 10.1093/brain/124.6.1091
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature05598
|2 Crossref
|o 10.1038/nature05598
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.20241
|2 Crossref
|o 10.1002/ana.20241
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.2173143
|2 Crossref
|o 10.1126/science.2173143
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.1994.00540230033009
|2 Crossref
|o 10.1001/archneur.1994.00540230033009
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0960-8966(96)00418-X
|2 Crossref
|o 10.1016/S0960-8966(96)00418-X
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.20905
|2 Crossref
|o 10.1002/ana.20905
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.nmd.2004.04.006
|2 Crossref
|o 10.1016/j.nmd.2004.04.006
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.pediatrneurol.2007.09.007
|2 Crossref
|o 10.1016/j.pediatrneurol.2007.09.007
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0022-510X(02)00270-8
|2 Crossref
|o 10.1016/S0022-510X(02)00270-8
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.20402
|2 Crossref
|o 10.1002/humu.20402
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archopht.124.6.885
|2 Crossref
|o 10.1001/archopht.124.6.885
999 C 5 |9 -- missing cx lookup --
|a 10.1046/j.1532-5415.2001.49998.x
|2 Crossref
|o 10.1046/j.1532-5415.2001.49998.x
999 C 5 |9 -- missing cx lookup --
|a 10.1080/07853890802186905
|2 Crossref
|o 10.1080/07853890802186905
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.282.5391.1075
|2 Crossref
|o 10.1126/science.282.5391.1075
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1072994
|2 Crossref
|o 10.1126/science.1072994
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ng1718
|2 Crossref
|o 10.1038/ng1718
999 C 5 |9 -- missing cx lookup --
|a 10.1086/302553
|2 Crossref
|o 10.1086/302553
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tig.2008.01.004
|2 Crossref
|o 10.1016/j.tig.2008.01.004
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.20651
|2 Crossref
|o 10.1002/humu.20651
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0140-6736(96)90857-0
|2 Crossref
|o 10.1016/S0140-6736(96)90857-0
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.21426
|2 Crossref
|o 10.1002/ana.21426
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.20520
|2 Crossref
|o 10.1002/humu.20520
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000187068.92184.63
|2 Crossref
|o 10.1212/01.wnl.0000187068.92184.63


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21